Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems

The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype

Andrea Gaedigk, S.D. Simon, R PEARCE et al. · Clinical Pharmacology & Therapeutics · 2007 · 793 citations

Medicine, Pharmacokinetics, Pharmacology +16

Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography–tandem mass spectrometry analysis in hospital effluent wastewaters

María José Gómez, Mira Petrović, Amadeo R. Fernández‐Alba et al. · Journal of Chromatography A · 2006 · 505 citations

Natural Sciences, Chemistry, Pharmaceutical Analysis +16

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

J. Kevin Hicks, Jesse J. Swen, Caroline F. Thorn et al. · Clinical Pharmacology & Therapeutics · 2013 · 453 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

The relationship between paroxetine and the sparteine oxidation polymorphism

Søren H. Sindrup, Kim Brøsen, Lars F. Gram et al. · Clinical Pharmacology & Therapeutics · 1992 · 207 citations

Medicine, Pharmacokinetics, Pharmacology +14

CYP2D6 and ABCB1 Genetic Variability: Influence on Paroxetine Plasma Level and Therapeutic Response

Marianne Gex‐Fabry, Chin B. Eap, Beatrice Oneda et al. · Therapeutic Drug Monitoring · 2008 · 159 citations

Pharmacy, Pharmacokinetics, Pharmacology +17